| MicroRNA-375 suppresses the growth and invasion of fibrolamellar carcinoma TA Dinh, ML Jewell, M Kanke, A Francisco, R Sritharan, RE Turnham, ... Cellular and molecular gastroenterology and hepatology 7 (4), 803-817, 2019 | 34 | 2019 |
| Hotspots of aberrant enhancer activity in fibrolamellar carcinoma reveal candidate oncogenic pathways and therapeutic vulnerabilities TA Dinh, R Sritharan, FD Smith, AB Francisco, RK Ma, RP Bunaciu, ... Cell reports 31 (2), 2020 | 24 | 2020 |
| Multiomic analysis of microRNA-mediated regulation reveals a proliferative axis involving miR-10b in fibrolamellar carcinoma AB Francisco, M Kanke, AP Massa, TA Dinh, R Sritharan, K Vakili, ... JCI insight 7 (11), 2022 | 9 | 2022 |
| Super-enhancer signature reveals key mechanisms associated with resistance to non-alcoholic steatohepatitis in humans with obesity Y Hung, R Sritharan, M Vohl, O Ilkayeva, L Biertho, A Tchernof, PJ White, ... | 1 | 2021 |
| Liver enhancer signature and regulatory network of non-alcoholic steatohepatitis resistance in humans with obesity YH Hung, R Sritharan, MC Vohl, O Ilkayeva, L Biertho, A Tchernof, ... bioRxiv, 2021.08. 20.457162, 2021 | 1 | 2021 |
| Genomic alterations in intrahepatic cholangiocarcinoma SE Young, R Sritharan, D Sia DOI: 10.20517/2394-5079.2023.37, 2023 | | 2023 |
| Hotspots of aberrant enhancer activity in fibrolamellar carcinoma reveal molecular mechanisms of oncogenesis and intrinsic drug resistance TA Dinh, R Sritharan, FD Smith, AB Francisco, RK Ma, RP Bunaciu, ... bioRxiv, 2020.01. 18.911297, 2020 | | 2020 |
